| Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation J Wei, J Shimazu, MP Makinistoglu, A Maurizi, D Kajimura, H Zong, ... Cell 161 (7), 1576-1591, 2015 | 415 | 2015 |
| MC4R-dependent suppression of appetite by bone-derived lipocalin 2 I Mosialou, S Shikhel, JM Liu, A Maurizi, N Luo, Z He, Y Huang, H Zong, ... Nature 543 (7645), 385-390, 2017 | 363 | 2017 |
| The Great Beauty of the osteoclast A Cappariello, A Maurizi, V Veeriah, A Teti Archives of biochemistry and biophysics 558, 70-78, 2014 | 291 | 2014 |
| The osteoclast in bone metastasis: player and target A Maurizi, N Rucci Cancers 10 (7), 218, 2018 | 151 | 2018 |
| Osteoblast‐derived extracellular vesicles are biological tools for the delivery of active molecules to bone A Cappariello, A Loftus, M Muraca, A Maurizi, N Rucci, A Teti Journal of Bone and Mineral Research 33 (3), 517-533, 2018 | 115 | 2018 |
| Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate R Thaler, A Maurizi, P Roschger, I Sturmlechner, F Khani, S Spitzer, ... Journal of Biological Chemistry 291 (13), 6754-6771, 2016 | 65 | 2016 |
| Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry M Capulli, D Hristova, Z Valbret, K Carys, R Arjan, A Maurizi, F Masedu, ... British Journal of Cancer 121 (2), 157-171, 2019 | 62 | 2019 |
| A complex role for lipocalin 2 in bone metabolism: global ablation in mice induces osteopenia caused by an altered energy metabolism M Capulli, M Ponzetti, A Maurizi, S Gemini‐Piperni, T Berger, TW Mak, ... Journal of Bone and Mineral Research 33 (6), 1141-1153, 2018 | 51 | 2018 |
| Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models I Alam, AK Gray, K Chu, S Ichikawa, KS Mohammad, M Capannolo, ... Bone 59, 66-75, 2014 | 40 | 2014 |
| Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis P Di Benedetto, P Ruscitti, O Berardicurti, N Panzera, N Grazia, ... Arthritis Research & Therapy 23, 1-12, 2021 | 30 | 2021 |
| Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation A Cappariello, R Paone, A Maurizi, M Capulli, N Rucci, M Muraca, A Teti Biomaterials 46, 58-69, 2015 | 25 | 2015 |
| Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 M Capulli, A Maurizi, L Ventura, N Rucci, A Teti Molecular Therapy-Nucleic Acids 4, 2015 | 25 | 2015 |
| RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development A Maurizi, M Capulli, R Patel, A Curle, N Rucci, A Teti Bone 110, 343-354, 2018 | 24 | 2018 |
| Effect of rapamycin on bone mass and strength in the α2 (I)‐G610C mouse model of osteogenesis imperfecta JF Bateman, L Sampurno, A Maurizi, SR Lamandé, NA Sims, TL Cheng, ... Journal of Cellular and Molecular Medicine 23 (3), 1735-1745, 2019 | 22 | 2019 |
| A roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders MM Formosa, DJM Bergen, CL Gregson, A Maurizi, A Kämpe, ... Frontiers in Endocrinology 12, 709711, 2021 | 16 | 2021 |
| Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy M Ponzetti, A Ucci, A Maurizi, L Giacchi, A Teti, N Rucci International Journal of Molecular Sciences 23 (2), 958, 2022 | 15 | 2022 |
| Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications A Maurizi, M Capulli, A Curle, R Patel, A Ucci, JA Côrtes, H Oxford, ... Bone Research 7 (1), 17, 2019 | 14 | 2019 |
| Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS A Ucci, A Cappariello, M Ponzetti, F Tennant, AEP Loftus, K Shefferd, ... Bone 153, 116130, 2021 | 11 | 2021 |
| Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women A Maurizi, M Ponzetti, KM Gautvik, S Reppe, A Teti, N Rucci Bone Reports 14, 101059, 2021 | 11 | 2021 |
| Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine C Paganini, CG Tota, L Monti, I Monti, A Maurizi, M Capulli, M Bourmaud, ... Biochemical Pharmacology 185, 114452, 2021 | 10 | 2021 |
